Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

c_ssilver-fotolia_ebr_jul_2014

Clinical Trial Transparency

September 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trial, clinical trial transparency, transparency

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …
Feature
ole_isacson

Pfizer appoints new chief scientific officer for neuroscience research

September 7, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Ole Isacson has been named as the chief scientific officer at Pfizer’s neuroscience research unit. He will continue to …
Appointment
brent_saunders

Allergan CEO outlines ‘social contract with patients’

September 7, 2016 Research and Development, Sales and Marketing Allergan, Brent Saunders, CEO, blog

Highlighting a recent shift in the priorities of the pharmaceutical industry, Allergan CEO and president Brent Saunders has outlined a …
News
allergan

Allergan acquires biotech Retrosense for $60 million

September 7, 2016 Research and Development, Sales and Marketing Allergan, Retrosense, acquisition

Allergan has announced that it has acquired Retrosense, a biotech focused on novel gene therapy approaches to restore vision in …
News
legal

Antitrust investigation launched into Mylan and the EpiPen scandal

September 7, 2016 Research and Development, Sales and Marketing Mylan, US, antitrust, epipen, investigation, lawmakers, scandal

The New York attorney general has commenced an investigation into Mylan Pharmaceuticals, after an initial review indicated that the company …
News
bms

European Commission approves new RA treatment from BMS

September 6, 2016 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, EMA, EU, Orencia, RA, abatacept, approval, rheumatoid arthritis

Bristol-Myers Squibb has received approval from the European Commission for rheumatoid arthritis (RA) treatment Orencia (abatacept), making it the first …
News

Bayer takes another shot at Monsanto acquisition

September 6, 2016 Manufacturing and Production, Sales and Marketing Bayer, acqusition, monsanto

Bayer has made another move to acquire US-based Monsanto, raising the price it is prepared to pay in an effort …
News
shutterstock_254160583

Taiho invests in Arcus Biosciences as part of $70 million deal

September 6, 2016 Manufacturing and Production, Sales and Marketing Arcus, investment, taiho

Taiho Ventures has invested in California-based Arcus Biosciences alongside GV, Invus, DROIA Oncology Ventures and Stanford University as part of …
News
rd_hands

Takeda secures $312 million zika vaccine development contract

September 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Takeda, US government, Zika, world health organization

Takeda has announced that it has been granted a $312 million contract from the US government to develop an inactivated, …
News
hils

Clinton announces plan to tackle “unjustified price hikes”

September 5, 2016 Sales and Marketing Drug pricing, Shkreli, US, clinton, generic drugs, president, price hikes

US Presidential candidate Hillary Clinton has outlined a wide-ranging set of proposals to tackle what she calls the “unjustified price …
News
gsk_boronia_australia

GSK announce positive results for chronic obstructive pulmonary disease treatment

September 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing GlaxoSmithKline, Innoviva, Revlar Ellipta, chronic obstructive pulmonary disease

GlaxoSmithKline and its partner Innoviva have announced that its Relvar Ellipta achieved positive results in its COPD Salford lung study …
News
merck_and_co

MSD drops osteoporosis trial drug due to stroke risk

September 5, 2016 Research and Development, Sales and Marketing MSD, Merck, Odanacatib, osteoporosis, stroke

MSD, known as Merck in the US and Canada, has announced that it has finally decided to discontinue the development …
News
astrazeneca_sign_sky

AZ’s first respiratory biologic meets primary endpoints in Phase III trials

September 5, 2016 Research and Development, Sales and Marketing AstraZeneca, asthma, benralizumab, biologic, respiratory, severe asthma

AstraZeneca has presented Phase III data at the European Respiratory Society (ERS) international congress which shows that trial biologic benralizumab …
News
top_ten

Top ten stories in the pharmaceutical industry this week

September 2, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile.com, top ten

As Mylan is left reeling from the backlash on its EpiPen price increase in the US, many lost their jobs …
News
amgen_flag

Amgen’s leukaemia treatment given FDA thumbs up for use in paediatric patients

September 2, 2016 Medical Communications, Sales and Marketing Amgen, FDA, blincyto, leukaemia

Amgen has announced that the FDA has approved the supplemental Biologics License Application for Blincyto (blinatumomab) in the treatment of …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026